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Abstract 
Background: Cardiac surgery and sternotomy are procedures accompanied by 
substantial postoperative pain which is challenging to treat. Generally, intravenous opioids 
are used in the immediate postoperative phase, followed by oral opioids. Oral opioids are 
easier to use, and generally less expensive. Our goal was thus to determine whether a 
new opioid preparation provides adequate analgesia after sternotomy. In particular, we 
tested the primary hypothesis that total opioid use (in morphine equivalents) is not greater 
with oral opioid compared with patient-controlled intravenous morphine. Our secondary 
hypothesis was that analgesic efficacy is similar with oral and intravenous opioids.  
Methods: We enrolled 51 patients having elective cardiac surgery. After rapid 
postoperative respiratory weaning, patients were randomised in one of two types of 
analgesia: oral Targin (a combination of oxycodone-hydrochloride and the opioid 
antagonist naloxone hydrochloride-dihydrate) or patient-controlled intravenous morphine. 
Pain Score (visual analogue scale), sedation (Ramsey score), respiratory rate, and side 
effects were assessed 3, 5, 7, 9, and 11 hours after surgery, and every six hours through 
the third postoperative evening.  
Results: The total opioid dose in morphine equivalent doses was significantly lower 
with oral opioid (34 [29, 38] mg) than with intravenous morphine (69 [61, 78] mg) (adjusted 
geometric means [95% confidence interval]). Furthermore, pain scores were similar in 
each group.  
Conclusions: Analgesic quality was comparable with oral and intravenous opioids, 
suggesting that oral opioids can be sufficient even after very painful procedures.  
 
Introduction 
Skin incisions, intraoperative tissue retraction and dissection, intravasal 
cannulations and drainages, sternotomy, and pericardiotomy all contribute to intense pain 
after cardiac surgery.1, 2 As might be expected, treatment of such pain remains 
challenging.(1) Poorly controlled thoracic pain may contribute directly or indirectly to 
postoperative complications including myocardial ischemia, hypoventilation and 
atelectasis, delayed return of gastrointestinal function, and decreased mobility.(2-3) There 
is also a strong association between prolonged acute pain and subsequent development 
of persistent incisional pain.4 
Opioids are the most commonly used medications for treatment of acute severe 
postoperative pain, and their analgesic efficacy is undisputed. Opioids are usually given 
intravenously during the initial postoperative days, and then continued orally. Patient-
controlled analgesia (PCA) is widely used and effective,(4) but requires trained staff and 
expensive equipment.(5)  
Once patients tolerate oral medications, oral administration is preferred because it 
is convenient, non-invasive, easier, and generally less expensive.(2) Early postoperative 
administration of oral opioids would therefore facilitate analgesic management and 
presumably reduce healthcare costs. Our goal was to determine whether a oral opioid 
preparation, Targin (a combination of oxycodone hydrochloride and the opioid antagonist 
naloxone hydrochloride dihydrate), provides postoperative analgesia comparable to that 
provided by intravenous PCA. In particular, we tested the primary hypothesis that total 
opioid use (in morphine equivalents) is smaller with oral opioid compared with PCA 
intravenous morphine.  
 
Methods 
Our study was registered at clinicaltrials.gov (NCT01816581) and conducted in the 
Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care Medicine at 
the Medical University of Vienna. With approval from the Ethics Committee of the Medical 
University Vienna and written informed consent, we enrolled fifty-one patients scheduled 
for elective conventional on-pump cardiac surgery requiring a median sternotomy  
between July 2011 and May 2012.  
Patients were randomly allocated to postoperative oral opioid (oral group) or 
intravenous patient-controlled analgesia morphine (PCA group). Targin is a controlled-
release oral medication, consisting of a fixed ratio of two drugs: the opioid oxycodone 
hydrochloride (20 mg) and the opioid antagonist naloxone hydrochloride dihydrate (10 mg) 
per tablet. Oxycodone is a potent semi-synthetic opioid analgesic that has been in clinical 
use since 1917 for the treatment of severe pain.(6) It is effective in severe chronic pain, 
whether nociceptive, cancer-related or neuropathic pain.(7) Naloxone is a potent µ-
receptor antagonist.  
All patients had American Society of Anesthesiologists (ASA) physical status 
scores 3 or 4, were aged 18 to 90 years, and expected to be extubated within four 
postoperative hours. Exclusion criteria were: chronic use of opioids, tranquilizers or pain 
medications within three months; hypersensitivity to opioids; use of monoamine oxidase 
inhibitors in the two weeks before surgery; alcohol or drug abuse; renal dysfunction 
(GFR < 30 or need for dialysis); liver dysfunction defined as Child-Pugh Score 7-15; 
ejection fraction < 40%; malabsorption syndrome; neurologic or cognitive dysfunction; 
 
pregnancy; severe respiratory depression; severe chronic obstructive pulmonary disease; 
severe bronchial asthma; non-opioid induced paralytic ileus; and history of seizures. 
We observed that in recent years at the Medical University of Vienna, patients 
recovering from sternotomy required about 50 ± 15 (SD) mg intravenous morphine 
sulphate during the first three postoperative days. We thus estimated that 72 patients 
would provide 80% power at an alpha level of 5% based on a 20% treatment effect. 
Because cardiac surgery is a difficult study setting and there was thus substantial potential 
for patients dropping out, we planned to enrol 100 patients. 
Protocol 
Patients were premedicated with up to 7.5 mg midazolam. General anaesthesia 
was induced with fentanyl 3 µg/kg, propofol 1.5 mg/kg, and rocuronium 0.6 mg/kg. 
General anaesthesia was maintained with sevoflurane combined with 0.2 to 0.4 µg/kg/min 
remifentanil as clinically necessary. Thirty minutes before the anticipated end of surgery, 
patients were given 1 g paracetamol intravenously. After end of surgery, patients were 
transferred to the ICU, still intubated and ventilated, and remifentanil was reduced to 0.05 
µg/kg/min. Remifentanil was discontinued three hours after surgery. Patients were 
thereafter given 1 g paracetamol intravenously at six-hour intervals throughout the first 
three postoperative days. 
Using a “fast track” approach, patients were weaned from mechanical ventilation 
and extubated as quickly as possible. Two hours after extubation, patients were tested for 
the ability to swallow. Patients were only randomised if swallowing was successful, and the 
swallowing test was assigned time zero. Randomisation (1:1) without stratification was 
 
based on computer-generated codes, that were kept in sequentially numbered opaque 
envelopes. 
Patients assigned to PCA group were given a basal rate of 0.3 mg morphine per 
hour. The demand dose was a 1 mg bolus with a five-minute lockout, but no other hourly 
limit. Patients assigned to oral group were given 20 mg Targin tablets at 12-hour intervals, 
corresponding to a daily dose of 36 mg oxycodone. On their demand or when visual 
analogue scores (see below) exceeded 30 mm, patients were given an additional 5 mg 
oxycodone hydrochloride which was repeated as necessary at 30-minute intervals.  
Measurements 
Patients were instructed in the Visual Analogue Scale (VAS) and the Patient 
Controlled Analgesia (PCA) pump the day before surgery. The VAS was evaluated using a 
slide rule which ranged from 0 mm (no pain) to 100 mm (worst pain).(8-9) 
Three hours after extubation, patients rated their pain using a visual analogue 
scale. We simultaneously recorded impairment of consciousness using the Ramsay 
Sedation Scale,(10) spontaneous respiratory rate, and potential side effects including 
nausea, vomiting, anorexia, dizziness, headache, and itching.  
VAS Score, Ramsey Sedation Score,(10) spontaneous respiratory rate, time of first 
defecation, and potential side effects were also assessed 3, 5, 7, 9, and 11 hours after end 
of surgery. The same measurements were also made every six hours through the third 
postoperative evening.   
 
Statistical analysis 
All postoperative opioid administrations were converted to intravenous morphine 
equivalent doses with 20 mg of Targin being considered equivalent to 18 mg oral 
oxycodone and, therefore, to 9 mg of intravenous morphine.(11-15)  
Although the assignment of patients to oral or PCA group was random, the risk of 
chance imbalance on potential confounding variables nonetheless existed due to the 
relatively small sample size of our study. We thus initially compared the randomised 
groups with respect to balance on baseline and intraoperative characteristics. Balance 
was assessed using standard univariable summary statistics as well as standardised 
difference scores (Austin PC, 2009, #24). The standardised difference score is an index 
that measures the magnitude of difference between groups on baseline variables; it is 
calculated as the difference in means, mean rankings, or proportions divided by a common 
measure of standard deviation across the two groups. Any baseline or intraoperative 
characteristic displaying imbalance as characterised by a standardised difference greater 
than 0.1 in absolute value was considered for adjustment in all analyses comparing 
randomised groups. 
To evaluate the primary hypothesis comparing the randomised groups on total IV 
morphine equivalent dose, we developed a linear regression model. We applied the 
logarithmic transformation to morphine equivalent doses prior to modelling in order to 
model percent differences between groups. Any imbalanced baseline variables (as per the 
criterion above) were considered for entry into the model; backward stepwise variable 
selection, with a selection criteria set conservatively at P<0.30, was used to obtain the final 
 
multivariable model. The Wald test for regression model coefficients was employed to test 
for significance of treatment effect with Type I error rate set at 5%.  
To study the effect of oral opiate medication on pain score we used a linear mixed 
model (16). This model allows for estimation of mean pain scores as a function of 
postoperative time while adjusting confidence interval estimates to accommodate for the 
correlation present among repeated pain measurements obtained from a given patient (we 
used a spatial power correlation structure, which assumes a greater degree of correlation 
among pain score measurements close together in time than among measurements 
distant in time from one another). Similarly, a linear mixed model was used to compare 
two randomised groups based on the rate of spontaneous breathing.  
Regarding the impairment of consciousness in Ramsay Sedation Scale, we only 
observed levels I, II and III through all postoperative days with 63% of the times detecting 
level II and 36% of the times - level III. To assess the level of sedation in the exploratory 
groups we transformed data into a binary variable (i.e., sedation score of III versus I/II). 
Then we used a logistic mixed model with adjustment for the correlation among repeated 
measures as for pain scores.  
Likely complications (nausea, vomiting, anorexia, dizziness, headache and itching) 
were summarised into a collapsed composite binary outcome (i.e., any versus none). The 
odds of experiencing one or more complications were compared between oral and control 
groups using logistic regression analysis (adjusting for the same factors as in the primary 
analysis). Incidence of each individual complication and constipation difficulties were also 
reported for each group. 
 
Wald tests for regression model coefficients were used for each of the secondary 
hypotheses; the Bonferroni correction was applied in order to control the overall Type I 
error rate at 5% for these secondary hypothesis tests.(17) R statistical software version 
2.15.2 for 64-bit Unix operating system (The R Foundation for Statistical Computing, 
Vienna, Austria) was used for all analysis.  
  
 
Results 
The study enrolment was discontinued after 51 patients when the principal 
investigator (KR) moved from the University of Vienna to the University of Zurich. One of 
the 51 patients requested exclusion from the study 54 hours after randomization to the oral 
opiod group because of subjective discomfort. Thus, a total of 50 patients were included in 
the analysis: 24 were given oral opioids and 26 intravenous opioids.  
Baseline and intraoperative characteristics of the two study groups are shown in 
Table 1. Patients randomised to oral group, by chance, were slightly older, more likely to 
be female, with lower American Society of Anesthesiologists’ Physical Status, had a lower 
body mass index (BMI), shorter surgery, and were mechanically ventilated slightly longer. 
We thus adjusted for these factors in all analyses.  
Outcome variables are summarised in Table 2. As for the primary outcome, 
backward stepwise variable selection led to a final multivariable model with the following 
baseline potential confounding variables: age, BMI, type of surgery, and duration of 
surgery. Adjusting for these variables, we found that the total IV morphine equivalent dose 
was significantly lower for oral group than PCA group (Wald test P<0.001). Adjusted 
geometric mean [95% confidence interval] morphine equivalent doses were 34 [29, 38] mg 
and 69 [61, 78] mg for the oral and IV groups, respectively, and the corresponding ratio 
[95% confidence interval] of geometric means was 0.49 [0.41, 0.58]. The unadjusted 
observed median [1st quartile, 3rd quartile] morphine equivalent doses were 32 [29, 34] 
mg and 84 [45, 95] mg for the oral and IV groups, respectively. 
Adjusted VAS pain score estimates as a function of postoperative time for each 
group are shown in Figure 1. Based on the figure, estimates appeared slightly higher in the 
 
oral group than in the PCA group. However, we found no significant time-dependence of 
the treatment effect in our sample (group-time interaction F-test P=0.99) and furthermore 
no overall treatment effect of oral opioids after removing the group-time interaction 
(adjusted difference in mean VAS pain scores [98.7% confidence interval] of 3.4 [-4.3, 
11.2] points comparing the oral group to the PCA group; Wald test P=0.37, using a 
significance criterion of 0.05/4=0.0125; Table 2). Adjusted mean [98.7% confidence 
interval] VAS pain scores were 18 [13, 22] points and 14 [10, 18] points for the oral and IV 
groups, respectively; the unadjusted observed time-weighed mean [98.7% confidence 
interval] pain scores were 17 [0, 44] and 14 [0, 41] points for the oral and IV groups. 
For the other secondary outcomes (Table 2), we found no significant group effect 
on either the spontaneous respiratory rate or the likelihood of being deeply sedated after 
covariate adjustment (Wald test P=0.79 and P=0.85 respectively). Likewise, odds of side 
effects did not differ significantly (adjusted odds ratio [98.7% confidence interval] 
comparing oral to IV groups of 0.27 [0.05, 1.48]; Wald test P=0.06) Side effects are 
summarised in Table 3. For the given sample, patients given oral opioids had fewer side 
effects except vomiting. Observed median length of ICU stay [1st quartile, 3rd quartile] 
was 1 [1, 2] days for both groups, while hospital duration was 8.5 [8, 12] days for the oral 
group and 9 [8, 11] days for the PCA group. 
Discussion 
Cardiac surgery with median sternotomy provokes considerable postoperative pain. 
Our results indicate that administration of oral opioids provided comparable analgesia to 
intravenous PCA, while actually reducing overall opioid dose in morphine equivalents. And 
 
although our study was not powered for differences in side effects, it appears that reduced 
opioid dose with oral administration may also reduce opioid-induced complications. 
Oral administration of controlled-released tablets is not generally recommended 
during the initial postoperative day because of concerns about delayed drug absorption in 
the presence of decreased gastric emptying.(18-19) Furthermore, Valtola et al. concluded, 
that absorption of oral drugs is low within the first 48 hours after cardiac surgery.(20) 
However, we found oral administration to be effective which is consistent with previous 
studies in patients undergoing non-cardiac operations.(5, 21) For example, Duellman et al. 
reported that multimodal, pre-emptive analgesia including oxycodone is associated with 
lower opioid consumption and shorter hospitalization after orthopaedic surgery.(22) 
Similarly, Rothwell et al. reported that oral analgesics were comparable to intravenous 
morphine after total hip replacement.(5)  
A common complication of opioids is paralytic ileus which can occur with either oral 
or intravenous administration.(2) Ileus, though, is most common after gastro-intestinal 
surgery — especially after colon resection. We did not observe ileus in any of our patients, 
suggesting that the complication is relatively rare in cardiac patients. The incidence of 
opioid-induced respiratory and hemodynamic effects depends on the definition, the route 
of administration, and the specific opioid given.(23) However, Ramsey Sedation Scores 
and spontaneous respiratory rates were comparable in both of our study groups.  
The major limitation of our study is low power for detecting clinically-important 
effects of oral opioid administration on complications, a limitation that was worsened when 
the study was stopped for administrative reasons after only half the planned enrolment. 
Furthermore, the study was not double-blinded for organizational and administrative 
 
reasons. It is thus possible that opioid administration route influenced patients’ subjective 
responses, including pain perception. But to the extent that pain perception was biased by 
administration route, one might expect that most patients would consider intravenous 
treatment to be more potent.  
In summary, this is the first randomised trial of exclusive oral versus intravenous 
opioids for treatment of pain after sternotomy. Analgesic quality was comparable with each 
approach, suggesting that oral opioids can be sufficient even after very painful procedures 
and already at early stage after surgery.  
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